NCT04514926View on ClinicalTrials.gov

Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions
AsthmaTherapeutic Proteins
Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Francisco

OTHER

NCT04514926 - Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins | Biotech Hunter | Biotech Hunter